[神经病学家对药物诱导的帕金森症的看法]
1Department of Neurology, Graduate School of Medicine, Hirosaki University.
Brain and nerve = Shinkei kenkyu no shinpo
|June 16, 2025
概括
药物诱导的帕金森症 (DIP) 模仿异常性帕金森病,由多巴胺受体阻断剂引起. 早期识别和管理,包括药物调整,对患者至关重要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物诱导的帕金森症 (DIP) 是一种常见的阳性运动障碍.
- DIP的临床特征与异常性帕金森病 (PD) 无法区分.
研究的目的:
- 审查DIP的流行病学,病理生理学,临床特征,诊断测试和治疗.
- 强调在服用多巴胺受体阻断剂 (DRBA) 的患者中怀疑DIP的重要性.
主要方法:
- 流行病学,病理生理学,临床表现,诊断工具和DIP的治疗策略的文献综述.
- 对诊断标准的分析,包括要求先前接触DRBA.
主要成果:
- DIP诊断需要DRBA暴露史,并呈现帕金森症症状.
- 辅助测试,如DaT扫描,可以帮助区分DIP和前期PD.
- 治疗包括停止或调整致病原体,同时可能需要L-多巴治疗并发性PD.
结论:
- 临床医生应在DRBA治疗中出现亚急性帕金森症的患者中保持对DIP的高度怀疑指数.
- 及时识别和干预,包括药物修改,对于管理DIP至关重要.
- 区分DIP和prodromalPD指导适当的治疗策略,可能涉及L-dopa.
相关概念视频
01:15Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
01:37Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
01:28Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
01:28Disorders of the Nervous Tissue
1.7K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.7K